Drugs Infusion System Market Size & CAGR (2023-2031)
The Drugs Infusion System Market is expected to register a CAGR of 7.4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX million by 2031.
The report is segmented by Drugs Infusion System Market by Product (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia Pump, Insulin Pump, Implantable Infusion System); Mode of Administration (Oncology, Diabetes, Analgesia, Nutrition, Hematology, Pediatric, Others); Application (Intravenous, Subcutaneous, Arterial, Epidural, Others); End-User (Hospitals, Ambulatory Surgical Centers, Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Drugs Infusion System Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Drugs Infusion System Market Segmentation
Product- Elastomeric Infusion System
- Disposable Infusion System
- Syringe Infusion System
- Peristaltic Pump
- Multi-Channel Pump
- Patient-Controlled Analgesia Pump
- Insulin Pump
- Implantable Infusion System
- Oncology
- Diabetes
- Analgesia
- Nutrition
- Hematology
- Pediatric
- Others
- Intravenous
- Subcutaneous
- Arterial
- Epidural
- Others
- Hospitals
- Ambulatory Surgical Centers
- Others
- Hospitals
- Ambulatory Surgical Centers
- Others
Strategic Insights
Drugs Infusion System Market Growth Drivers- Rise in Chronic Diseases: The market for drug infusion systems is significantly influenced by the increased prevalence of chronic illnesses like diabetes, cancer, and cardiovascular conditions. The need for precise and efficient drug delivery systems is increasing since these disorders frequently necessitate long-term pharmaceutical maintenance. For example, the growing number of diabetic people makes insulin pumps necessary, which fuels market growth.
- Aging Population: Another important aspect affecting market growth is an aging population. The need for infusion systems that can deliver medications precisely and safely over long periods of time is increased by the fact that older persons often need specialized care and long-term medication administration.
- Advanced Solutions: Effective drug infusion systems are essential for outpatient therapy as outpatient care facilities expand. The need for dependable and effective drug delivery systems is growing as more surgeries are carried out in ambulatory settings.Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Technological Advancements: Patient safety and treatment results are improved by advancements in medication infusion technology, such as smart infusion pumps with wireless connectivity and built-in safety features. These developments increase the precision of drug delivery and decrease medication errors, increasing the attractiveness of infusion systems to medical professionals.
- Home Healthcare: The need for portable and easy-to-use drug infusion devices is being driven by the growing popularity of home healthcare services. Devices that enable patients to self-administer medications at home are preferred by patients, which lowers hospital stays and medical expenses. The popularity of home-use ambulatory infusion pumps is one example of this trend.
- Reimbursement Policies: Healthcare facilities are finding it easier to implement modern drug infusion systems as a result of improved reimbursement legislation in several nations. By encouraging hospitals and clinics to invest in cutting-edge infusion technologies, this financial assistance propels market expansion. Such a factor has assisted the overall market growth in the recent past and is expected to continue a similar trend during the forecast period.
- Dose Error Reduction Systems (DERS): DERS, which combines a tailored drug library to ensure that scheduled infusions fall within specified dosage parameters, is a feature of smart infusion pumps. The technology sends out real-time alerts when a clinician enters a dosage that deviates from these guidelines. This feature ensures that patients receive the right dosage by reducing errors during programming and the infusion procedure.
- Innovation and Research Investment: With the advent of wireless connectivity, smart pumps can now interact directly with clinical systems such as Electronic Health Records (EHRs). Because of this connectivity, the pump can now access prescribing information straight from patient records, doing away with the need for human programming. Additionally, bi-directional connectivity makes it possible to return infusion data to the EHR, improving data accuracy and lowering the possibility of human mistake.
- Potential for New Treatment Paradigms: Several healthcare technologies can be linked with smart pumps to create closed-loop systems. By connecting infusion pump software to EHRs and Bar Code Medication Administration (BCMA) systems, this interoperability enhances patient safety. Medication errors are further decreased by this integration, which makes precise drug distribution and real-time patient monitoring during infusions possible.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Drugs Infusion System Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Drugs Infusion System Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Dose Error Reduction Systems (DERS)
Budgetary Constraints
Europe region is expected to witness a high growth rate in terms of CAGR after Asia Pacific region during the forecast period
Rise in chronic diseases
Asia Pacific region is expected to witness the highest growth during the forecast period
The Drugs Infusion System Market is estimated to witness a CAGR of 7.4% from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug Infusion Systems Market - By Product
1.3.2 Drug Infusion Systems Market - By Mode of Administration
1.3.3 Drug Infusion Systems Market - By Application
1.3.4 Drug Infusion Systems Market - By End-User
1.3.5 Drug Infusion Systems Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG INFUSION SYSTEMS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG INFUSION SYSTEMS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DRUG INFUSION SYSTEMS MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG INFUSION SYSTEMS - GLOBAL MARKET OVERVIEW
6.2. DRUG INFUSION SYSTEMS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ELASTOMERIC INFUSION SYSTEM
7.3.1. Overview
7.3.2. Elastomeric Infusion System Market Forecast and Analysis
7.4. DISPOSABLE INFUSION SYSTEM
7.4.1. Overview
7.4.2. Disposable Infusion System Market Forecast and Analysis
7.5. SYRINGE INFUSION SYSTEM
7.5.1. Overview
7.5.2. Syringe Infusion System Market Forecast and Analysis
7.6. PERISTALTIC PUMP
7.6.1. Overview
7.6.2. Peristaltic Pump Market Forecast and Analysis
7.7. MULTI-CHANNEL PUMP
7.7.1. Overview
7.7.2. Multi-Channel Pump Market Forecast and Analysis
7.8. PATIENT-CONTROLLED ANALGESIA PUMP
7.8.1. Overview
7.8.2. Patient-Controlled Analgesia Pump Market Forecast and Analysis
7.9. INSULIN PUMP
7.9.1. Overview
7.9.2. Insulin Pump Market Forecast and Analysis
7.10. IMPLANTABLE INFUSION SYSTEM
7.10.1. Overview
7.10.2. Implantable Infusion System Market Forecast and Analysis
8. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - MODE OF ADMINISTRATION
8.1. OVERVIEW
8.2. MODE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. DIABETES
8.4.1. Overview
8.4.2. Diabetes Market Forecast and Analysis
8.5. ANALGESIA
8.5.1. Overview
8.5.2. Analgesia Market Forecast and Analysis
8.6. NUTRITION
8.6.1. Overview
8.6.2. Nutrition Market Forecast and Analysis
8.7. HEMATOLOGY
8.7.1. Overview
8.7.2. Hematology Market Forecast and Analysis
8.8. PEDIATRIC
8.8.1. Overview
8.8.2. Pediatric Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. INTRAVENOUS
9.3.1. Overview
9.3.2. Intravenous Market Forecast and Analysis
9.4. SUBCUTANEOUS
9.4.1. Overview
9.4.2. Subcutaneous Market Forecast and Analysis
9.5. ARTERIAL
9.5.1. Overview
9.5.2. Arterial Market Forecast and Analysis
9.6. EPIDURAL
9.6.1. Overview
9.6.2. Epidural Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. DRUG INFUSION SYSTEMS MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
10.1. OVERVIEW
10.2. END-USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. AMBULATORY SURGICAL CENTERS
10.4.1. Overview
10.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
10.5. OTHERS.
10.5.1. Overview
10.5.2. Others. Market Forecast and Analysis
11. DRUG INFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Drug Infusion Systems Market Overview
11.1.2 North America Drug Infusion Systems Market Forecasts and Analysis
11.1.3 North America Drug Infusion Systems Market Forecasts and Analysis - By Product
11.1.4 North America Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration
11.1.5 North America Drug Infusion Systems Market Forecasts and Analysis - By Application
11.1.6 North America Drug Infusion Systems Market Forecasts and Analysis - By End-User
11.1.7 North America Drug Infusion Systems Market Forecasts and Analysis - By Countries
11.1.7.1 United States Drug Infusion Systems Market
11.1.7.1.1 United States Drug Infusion Systems Market by Product
11.1.7.1.2 United States Drug Infusion Systems Market by Mode of Administration
11.1.7.1.3 United States Drug Infusion Systems Market by Application
11.1.7.1.4 United States Drug Infusion Systems Market by End-User
11.1.7.2 Canada Drug Infusion Systems Market
11.1.7.2.1 Canada Drug Infusion Systems Market by Product
11.1.7.2.2 Canada Drug Infusion Systems Market by Mode of Administration
11.1.7.2.3 Canada Drug Infusion Systems Market by Application
11.1.7.2.4 Canada Drug Infusion Systems Market by End-User
11.1.7.3 Mexico Drug Infusion Systems Market
11.1.7.3.1 Mexico Drug Infusion Systems Market by Product
11.1.7.3.2 Mexico Drug Infusion Systems Market by Mode of Administration
11.1.7.3.3 Mexico Drug Infusion Systems Market by Application
11.1.7.3.4 Mexico Drug Infusion Systems Market by End-User
11.1.7.4 US Drug Infusion Systems Market
11.1.7.4.1 US Drug Infusion Systems Market by Product
11.1.7.4.2 US Drug Infusion Systems Market by Mode of Administration
11.1.7.4.3 US Drug Infusion Systems Market by Application
11.1.7.4.4 US Drug Infusion Systems Market by End-User
11.2. EUROPE
11.2.1 Europe Drug Infusion Systems Market Overview
11.2.2 Europe Drug Infusion Systems Market Forecasts and Analysis
11.2.3 Europe Drug Infusion Systems Market Forecasts and Analysis - By Product
11.2.4 Europe Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration
11.2.5 Europe Drug Infusion Systems Market Forecasts and Analysis - By Application
11.2.6 Europe Drug Infusion Systems Market Forecasts and Analysis - By End-User
11.2.7 Europe Drug Infusion Systems Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Drug Infusion Systems Market
11.2.7.1.1 Germany Drug Infusion Systems Market by Product
11.2.7.1.2 Germany Drug Infusion Systems Market by Mode of Administration
11.2.7.1.3 Germany Drug Infusion Systems Market by Application
11.2.7.1.4 Germany Drug Infusion Systems Market by End-User
11.2.7.2 France Drug Infusion Systems Market
11.2.7.2.1 France Drug Infusion Systems Market by Product
11.2.7.2.2 France Drug Infusion Systems Market by Mode of Administration
11.2.7.2.3 France Drug Infusion Systems Market by Application
11.2.7.2.4 France Drug Infusion Systems Market by End-User
11.2.7.3 Italy Drug Infusion Systems Market
11.2.7.3.1 Italy Drug Infusion Systems Market by Product
11.2.7.3.2 Italy Drug Infusion Systems Market by Mode of Administration
11.2.7.3.3 Italy Drug Infusion Systems Market by Application
11.2.7.3.4 Italy Drug Infusion Systems Market by End-User
11.2.7.4 Spain Drug Infusion Systems Market
11.2.7.4.1 Spain Drug Infusion Systems Market by Product
11.2.7.4.2 Spain Drug Infusion Systems Market by Mode of Administration
11.2.7.4.3 Spain Drug Infusion Systems Market by Application
11.2.7.4.4 Spain Drug Infusion Systems Market by End-User
11.2.7.5 United Kingdom Drug Infusion Systems Market
11.2.7.5.1 United Kingdom Drug Infusion Systems Market by Product
11.2.7.5.2 United Kingdom Drug Infusion Systems Market by Mode of Administration
11.2.7.5.3 United Kingdom Drug Infusion Systems Market by Application
11.2.7.5.4 United Kingdom Drug Infusion Systems Market by End-User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Drug Infusion Systems Market Overview
11.3.2 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis
11.3.3 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration
11.3.5 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By End-User
11.3.7 Asia-Pacific Drug Infusion Systems Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Drug Infusion Systems Market
11.3.7.1.1 Australia Drug Infusion Systems Market by Product
11.3.7.1.2 Australia Drug Infusion Systems Market by Mode of Administration
11.3.7.1.3 Australia Drug Infusion Systems Market by Application
11.3.7.1.4 Australia Drug Infusion Systems Market by End-User
11.3.7.2 China Drug Infusion Systems Market
11.3.7.2.1 China Drug Infusion Systems Market by Product
11.3.7.2.2 China Drug Infusion Systems Market by Mode of Administration
11.3.7.2.3 China Drug Infusion Systems Market by Application
11.3.7.2.4 China Drug Infusion Systems Market by End-User
11.3.7.3 India Drug Infusion Systems Market
11.3.7.3.1 India Drug Infusion Systems Market by Product
11.3.7.3.2 India Drug Infusion Systems Market by Mode of Administration
11.3.7.3.3 India Drug Infusion Systems Market by Application
11.3.7.3.4 India Drug Infusion Systems Market by End-User
11.3.7.4 Japan Drug Infusion Systems Market
11.3.7.4.1 Japan Drug Infusion Systems Market by Product
11.3.7.4.2 Japan Drug Infusion Systems Market by Mode of Administration
11.3.7.4.3 Japan Drug Infusion Systems Market by Application
11.3.7.4.4 Japan Drug Infusion Systems Market by End-User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Drug Infusion Systems Market Overview
11.4.2 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis
11.4.3 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration
11.4.5 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By End-User
11.4.7 Middle East and Africa Drug Infusion Systems Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Drug Infusion Systems Market
11.4.7.1.1 South Africa Drug Infusion Systems Market by Product
11.4.7.1.2 South Africa Drug Infusion Systems Market by Mode of Administration
11.4.7.1.3 South Africa Drug Infusion Systems Market by Application
11.4.7.1.4 South Africa Drug Infusion Systems Market by End-User
11.4.7.2 Saudi Arabia Drug Infusion Systems Market
11.4.7.2.1 Saudi Arabia Drug Infusion Systems Market by Product
11.4.7.2.2 Saudi Arabia Drug Infusion Systems Market by Mode of Administration
11.4.7.2.3 Saudi Arabia Drug Infusion Systems Market by Application
11.4.7.2.4 Saudi Arabia Drug Infusion Systems Market by End-User
11.4.7.3 U.A.E Drug Infusion Systems Market
11.4.7.3.1 U.A.E Drug Infusion Systems Market by Product
11.4.7.3.2 U.A.E Drug Infusion Systems Market by Mode of Administration
11.4.7.3.3 U.A.E Drug Infusion Systems Market by Application
11.4.7.3.4 U.A.E Drug Infusion Systems Market by End-User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Drug Infusion Systems Market Overview
11.5.2 South and Central America Drug Infusion Systems Market Forecasts and Analysis
11.5.3 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Product
11.5.4 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Mode of Administration
11.5.5 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Application
11.5.6 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By End-User
11.5.7 South and Central America Drug Infusion Systems Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Drug Infusion Systems Market
11.5.7.1.1 Brazil Drug Infusion Systems Market by Product
11.5.7.1.2 Brazil Drug Infusion Systems Market by Mode of Administration
11.5.7.1.3 Brazil Drug Infusion Systems Market by Application
11.5.7.1.4 Brazil Drug Infusion Systems Market by End-User
11.5.7.2 Argentina Drug Infusion Systems Market
11.5.7.2.1 Argentina Drug Infusion Systems Market by Product
11.5.7.2.2 Argentina Drug Infusion Systems Market by Mode of Administration
11.5.7.2.3 Argentina Drug Infusion Systems Market by Application
11.5.7.2.4 Argentina Drug Infusion Systems Market by End-User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DRUG INFUSION SYSTEMS MARKET, KEY COMPANY PROFILES
13.1. MEDTRONIC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. B. BRAUN MELSUNGEN AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAXTER
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ARCOMED AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. HALYARD HEALTH, INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ICU MEDICAL INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. INSULET CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TERUMO CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SMITHS GROUP PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TANDEM DIABETES CARE, INC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
- Medtronic
- B. Braun Melsungen AG
- Baxter
- Arcomed AG
- Halyard Health, INC
- ICU Medical Inc
- Insulet Corporation
- Terumo Corporation
- Smiths Group Plc
- Tandem Diabetes Care
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For